Nerbio iTOF
Remote monitoring software
Free
Nerbio’s iTOF® app works with the iTOF device; an FDA cleared, quantitative neuromuscular transmission (NMT) monitor for remote monitoring of neuromuscular blocking agents (NMBAs).
The iTOF app is designed to make patient monitoring safer, easier to use, and more accurate than ever. The iTOF is the first mobile device-managed, quantitative monitor of NMBAs. The combination of the app and Bluetooth-connected stimulator device allows precise, automated quantitative monitoring of the level of neuromuscular block. Wireless control also improves caregiver safety while maintaining a high-level of patient care. The iTOF system is recommended by leading anesthesiologists and used around the world for accurate NMBA monitoring.
-------------------------------
NOTE: This app requires the iTOF device hardware to perform monitoring. Contact nerbio.com for information. iTOF is a registered trademark of Nerbio Medical Software Platforms, Inc. San Jose, California USA.
-------------------------------
NOTE: Nerbio’s iTOF is authorized for use in the following countries:
USA
CHILE
COLOMBIA
INDIA
-------------------------------
Ratings & Reviews
-Misc. minor improvements
The developer, Nerbio Medical Software Platform Inc, indicated that the app’s privacy practices may include handling of data as described below. For more information, see the developer’s privacy policy .
Data Not Collected
The developer does not collect any data from this app.
Accessibility
The developer has not yet indicated which accessibility features this app supports. Learn More
Information
- Seller
- Nerbio Medical Software Platforms Inc.
- Size
- 91.4 MB
- Category
- Medical
- Compatibility
Requires iOS 15.6 or later.
- iPhone
Requires iOS 15.6 or later. - iPad
Requires iPadOS 15.6 or later. - iPod touch
Requires iOS 15.6 or later. - Apple Vision
Requires visionOS 1.0 or later.
- iPhone
- Languages
- English
- Age Rating
16+
- 16+
- Frequent
Medical Treatment information
- Copyright
- © 2025 Nerbio Medical Software Platforms Inc.